Management tracks: Neurocrine, Cellect, Marina

Neurology and endocrine company Neurocrine Biosciences Inc. (NASDAQ:NBIX) said President, COO and Interim CFO David-Alexander Gros is stepping down. CEO Kevin Gorman will serve as interim CFO while the company seeks a replacement.

Stem cell production company Cellect Biotechnology Ltd. (NASDAQ:APOP) said Chief Development Officer Yaron Pereg is stepping down. Ronit Bakimer-Kleiner, who was general manager of Cognate BioServices Inc. (Baltimore, Md.), will succeed Pereg...